Search Results for Therapeutics.

Protection from Pneumonic Plague by the Induction of Heme Oxygenase-1

Willix, Joshua, author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:13870053

Format:

Excerpt:

University of Missouri - Columbia. Molecular Pathogenesis and Therapeutics. degree granting

Synthetic Biology Approaches for Engineering Diverse Bacterial Species

Brophy, Jennifer Ann Noelani, author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10902883

Format:

Excerpt:

When engineers control gene expression, cells can be re-programmed to create living therapeutics or

Venezuelan Equine Encephalitis Virus Capsid and Host Nucleocytoplasmic Trafficking

Lundberg, Lindsay N., author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10789292

Format:

Excerpt:

Category B Pathogen by NIAID. There are no FDA-approved therapeutics or vaccines for human use. Thus, it is

Gut Microbiota Density Influences Host Physiology and is Shaped By Host and Microbial Factors

Contijoch, Eduardo J., author. (orcid)0000-0002-2873-6808

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10824826

Format:

Excerpt:

microbiota therapeutics and monitor their responses.

Nucleotide Metabolism in Salmonella Pathogenesis

Fitzsimmons, Liam Fry, author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10792366

Format:

Excerpt:

, generation of novel anti-Salmonella therapeutics becomes more pressing and will be aided by extensive

Examination of the Role of Envelope Directed Antibodies on Co-receptor Usage in HIV-1B Infection

Registre, Ludy, author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10751672

Format:

Excerpt:

implications for future antibody-based therapeutics.

Cover image for Evidence of Asymptomatic Carriage of Toxigenic Clostridioides difficile in Canines Suggests that Components of the Gut Microbiome Provide Resistance to Disease

Evidence of Asymptomatic Carriage of Toxigenic Clostridioides difficile in Canines Suggests that Components of the Gut Microbiome Provide Resistance to Disease

Stone, Nathan E., author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10811684

Format:

Excerpt:

gut could provide insights into targeted therapeutics for human CDI.

Cover image for Steroid- CoA Ligases, FadD17A1 and FadD19A1, and Their Role in Cholesterol Side-Chain Degradation in Mycobacterium tuberculosis

Steroid- CoA Ligases, FadD17A1 and FadD19A1, and Their Role in Cholesterol Side-Chain Degradation in Mycobacterium tuberculosis

Abou-Fadel, Johnathan Salim, author.

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10814786

Format:

Excerpt:

of ligase enzymes in this pathway for development of novel therapeutics capable of targeting the

Development of Protein Display Systems and Genetic Tools for Spore-Forming Bacteria

Drufva, Erin, author. (orcid)0000-0001-6497-9949

http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10815709

Format:

Excerpt:

diverse applications including biosynthesis, biocatalysis, therapeutics, drug delivery, and bioremediation

	{displayName}	{count}
{error}